Asahi Intecc Group announced that its consolidated subsidiary, Asahi Intecc Scientific (Beijing) Co., Ltd. has concluded an exclusive sales agreement with Dingke Medical Technology (Suzhou) Co., Ltd. (hereinafter referred to as "DK MEDTECH"), for the "DK ScoreTM Coronary Scoring Balloon Dilatation Catheter" manufactured by Chinese medical device company DK MEDTECH. Overview; In China, about 1.16 million cases of PCI (percutaneous coronary intervention) are performed in a year, and the number of cases is increasing over the medium to long term. In order to perform a large number of PCI procedures with a high success rate, proper pre-treatment of the stenosis becomes increasingly important. The "DK ScoreTM Coronary Scoring Balloon Dilatation Catheter" manufactured by DK MEDTECH is a useful balloon catheter for pre-treatment of stenotic areas, featuring excellent passage performance and dilatation. The Group has signed an exclusive sales agreement with DK MEDTECH for the "DK ScoreTM Coronary Scoring Balloon Dilatation Catheter" in the Chinese market from September 2022 to December 31, 2025. The Group has gained the top share of the global market for PCI guidewires. By providing more treatment options, the Group will contribute to the spread and development of minimally invasive treatment and
solidify overall number one position in the cardiovascular field. Contract signing date; September 22nd, 2022.
ASAHI INTECC CO., LTD. is a Japan-based company engaged in the manufacture and sale of products in the medical device field and industrial device field. The Company operates through two business segments. The Medical segment is engaged in the development, manufacture and sale of private label products and OEM products in the medical device field. The Device segment is engaged in the development, manufacture, and sale of components in the medical device field and industrial device field.